LEADER 00961nam a2200253 a 4500 001 991001450899707536 008 020 $a8822130588 035 $ab13374564-39ule_inst 040 $aDip.to di Studi Storici$bita 082 0 $a572.01 100 1 $aMaiocchi, Roberto$052968 245 10$aScienza italiana e razzismo fascista /$cRoberto Maiocchi 260 $aScandicci :$bLa nuova Italia,$c1999 300 $aVI, 338 p. ;$c21 cm 440 0$aBiblioteca di storia ;$v75 500 $aIn appendice: Il manifesto degli scienziati razzisti 650 4$aRazze umane$xTeorie$xItalia$y1920-1938 907 $a.b13374564$b21-09-06$c30-01-06 912 $a991001450899707536 945 $aLE023 572.01 MAI 1 1$g1$i2023000071854$lle023$o-$pE16.00$q-$rl$s- $t0$u1$v0$w1$x0$y.i14201173$z06-03-06 996 $aScienza italiana e razzismo fascista$9732585 997 $aUNISALENTO 998 $ale023$b - - $cm$da $e-$fita$git $h0$i0 LEADER 03675nam 2200709 450 001 996208659403316 005 20230721004930.0 010 $a1-283-51409-5 010 $a9786613826541 010 $a1-4443-0020-2 010 $a1-4443-0021-0 035 $a(CKB)1000000000715925 035 $a(EBL)416368 035 $a(SSID)ssj0000112114 035 $a(PQKBManifestationID)11819483 035 $a(PQKBTitleCode)TC0000112114 035 $a(PQKBWorkID)10081240 035 $a(PQKB)10357910 035 $a(MiAaPQ)EBC416368 035 $a(OCoLC)352745598 035 $a(EXLCZ)991000000000715925 100 $a20160805h20082008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBiomarkers in heart disease /$fedited by James A. de Lemos 210 1$aMalden, Massachusetts :$cBlackwell Publishing,$d2008. 210 4$d©2008 215 $a1 online resource (252 p.) 225 1 $aAHA Clinical Series 300 $a"American Heart Association." 311 $a1-4051-7571-0 320 $aIncludes bibliographical references and index. 327 $aContents; Contributors; Preface; Foreword; PART I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease; 1 Protocols for diagnosing myocardial infarction; 2 Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes; 3 Challenges interpreting cardiac troponin values; 4 Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease; 5 Novel markers in patients with suspected acute coronary syndromes; PART I I Biomarkers for Evaluation of Patients with Heart Failure 327 $a6 Use of natriuretic peptides in the diagnosis of heart failure7 Biomarkers for risk stratification in patients with heart failure; 8 Natriuretic peptides for disease monitoring in patients with chronic heart failure; PART I I I Biomarkers for Screening in Ambulatory Populations; 9 C-Reactive Protein; 10 Newer markers for population screening: focus on lipoprotein-related markers; PART I V A Look to the Future; 11 Moving toward personalized medicine; Index 330 $aBiomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine. The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scena 410 0$aAHA clinical series. 606 $aDiseases$xRisk factors$vMethods 606 $aBiochemical markers 606 $aHeart$xDiseases$xDiagnosis 606 $aHeart$xDiseases 606 $aHeart$xDiseases$xMolecular diagnosis 606 $aBiochemical markers$xDiagnostic use 615 0$aDiseases$xRisk factors 615 0$aBiochemical markers. 615 0$aHeart$xDiseases$xDiagnosis. 615 0$aHeart$xDiseases. 615 0$aHeart$xDiseases$xMolecular diagnosis. 615 0$aBiochemical markers$xDiagnostic use. 676 $a616.1/2075 676 $a616.12075 702 $ade Lemos$b James 712 02$aAmerican Heart Association. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996208659403316 996 $aBiomarkers in heart disease$92186530 997 $aUNISA LEADER 02047nam 2200433z- 450 001 9910346766603321 005 20210212 010 $a1000061838 035 $a(CKB)4920000000100856 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/59961 035 $a(oapen)doab59961 035 $a(EXLCZ)994920000000100856 100 $a20202102d2017 |y 0 101 0 $ager 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aStandard- und Modulbasierte digitale Rohbauprozesskette : Fru?hzeitige Produktbeeinflussung bezu?glich Produktionsanforderungen im Karosserierohbau der Automobilindustrie 210 $cKIT Scientific Publishing$d2017 215 $a1 online resource (XII, 205 p. p.) 225 1 $aReihe Informationsmanagement im Engineering Karlsruhe / Hrsg.: Karlsruher Institut für Technologie, Institut für Informationsmanagement im Ingenieurwesen (IMI) 311 08$a3-7315-0600-9 330 $aStandardization and modularization offers big advantages not only for the product development but also for production and planning departments. But industry often doesn't utilize these advantages. This contribution introduces a new method which supports the developer to design a new product in order to fit to the standardized and modularized production. 517 $aStandard- und Modulbasierte digitale Rohbauprozesskette 606 $aTechnology: general issues$2bicssc 610 $abody shop 610 $aKarosserierohbaumodul 610 $aModule 610 $aproduction 610 $aProduktion 610 $aStandardisierung 610 $astandardization 615 7$aTechnology: general issues 700 $aWalla$b Waldemar$4auth$01295472 906 $aBOOK 912 $a9910346766603321 996 $aStandard- und Modulbasierte digitale Rohbauprozesskette : Frühzeitige Produktbeeinflussung bezüglich Produktionsanforderungen im Karosserierohbau der Automobilindustrie$93023505 997 $aUNINA